BPC-157 + KPV + Larazotide
An oral, three-mechanism gut-inflammation and intestinal-barrier ("leaky gut") support stack aimed at people with IBD-adjacent symptoms, food-reactivity, or post-NSAID/post-infectious gut irritation. The stacking rationale is division of labor: Larazotide is claimed to shore up the tight-junction barrier, KPV to calm the cytokine cascade already triggered, and BPC-157 to drive the underlying tissue repair — "prevent, calm, rebuild" rather than one compound doing all three jobs.
Three oral peptides each target a different stage of gut damage: Larazotide tightens the "leaky gut" barrier (the seals between gut-lining cells), KPV calms inflammation, and BPC-157 drives tissue repair — the "prevent, calm, rebuild" idea.
